Dr. Peng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
676 N Saint Clair St
Ste 850
Chicago, IL 60611Phone+1 312-695-6180Fax+1 312-695-6189
Education & Training
Vanderbilt University School of MedicineClass of 2015
Certifications & Licensure
IL State Medical License 2023 - 2026
NY State Medical License 2019 - 2024
CT State Medical License 2017 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 26 citationsTargeting HER2 Exon 20 Insertion–Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor MobocertinibHan Han, Shuai Li, Ting Chen, Michael Fitzgerald, Shengwu Liu
Cancer Research. 2021-10-15 - 30 citationsClinical Activity of Ipilimumab in Acral Melanoma: A Retrospective ReviewDouglas B. Johnson, Chengwei Peng, Richard G. Abramson, Fei Ye, Shilin Zhao
The Oncologist. 2015-06-01 - 104 citationsNivolumab in melanoma: latest evidence and clinical potential.Douglas B. Johnson, Chengwei Peng, Jeffrey A. Sosman
Therapeutic Advances in Medical Oncology. 2015-02-02
Press Mentions
Omitting 5-FU Bolus Does Not Reduce Survival in Advanced CancerSeptember 11th, 2024
Melanoma Study Finds New Way to Enhance Targeted TherapiesMarch 9th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
